OrthoPediatrics Corp
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $236.3M | $204.7M | $148.7M | $122.3M | $98.0M | $71.1M | $72.6M | $57.6M |
| Cost of Revenue | $63.7M | $56.1M | $37.5M | $31.6M | $24.6M | $16.0M | $17.9M | $14.9M |
| Gross Profit | $172.7M | $148.6M | $111.3M | $90.7M | $73.4M | $55.0M | $54.6M | $42.7M |
| Gross Margin | 73.1% | 72.6% | 74.8% | 74.1% | 74.9% | 77.4% | 75.3% | 74.2% |
| Operating Expenses | ||||||||
| Research & Development | $9.1M | $11.0M | $10.9M | $8.5M | $5.5M | $5.3M | $5.7M | $4.7M |
| SG&A Expense | $119.8M | $102.8M | $73.3M | $57.9M | $46.1M | $38.3M | $26.7M | $20.9M |
| Operating Income | $-39.2M | $-35.0M | $-26.8M | $-25.4M | $-18.0M | $-26.8M | $-9.1M | $-9.6M |
| Operating Margin | -16.6% | -17.1% | -18.0% | -20.8% | -18.4% | -37.6% | -12.5% | -16.6% |
| Interest Expense | $27.0K | $35.0K | $42.0K | $525.0K | $56.0K | $3.4M | $3.5M | $2.3M |
| Pretax Income | $-39.2M | $-41.9M | $-21.3M | $-3.7M | $-17.4M | $-33.7M | $-12.7M | $-12.0M |
| Income Tax Expense | $460.0K | $-4.1M | $-338.0K | $-4.9M | $-1.1M | $-723.0K | $0 | $0 |
| Net Income | $-39.6M | $-37.8M | $-21.0M | $1.3M | $-16.3M | $-32.9M | $-13.7M | $-12.0M |
| Net Margin | -16.8% | -18.5% | -14.1% | 1.0% | -16.6% | -46.3% | -18.9% | -20.9% |
| EPS (Basic) | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-0.94 | $-0.96 |
| EPS (Diluted) | $-1.69 | $-1.64 | $-0.92 | $0.06 | $-0.84 | $-1.82 | $-0.94 | $-0.96 |
| Shares Outstanding (Basic) | 23.5M | 23.1M | 22.7M | 20.7M | 19.3M | 18.1M | 14.6M | 14.5M |
| Shares Outstanding (Diluted) | 23.5M | 23.1M | 22.7M | 20.9M | 19.3M | 18.1M | 14.6M | 14.5M |
| Dividends Per Share | — | — | — | — | — | — | — | — |